Evidence map›Paper›PMID 33046500›Full record

ArticleAntimicrobial agents and chemotherapy2020

Efficacy of Telavancin in Comparison to Linezolid in a Porcine Model of Severe Methicillin-Resistant Staphylococcus aureus Pneumonia.

D Battaglini, A Motos, G Li Bassi, H Yang, F Pagliara, M Yang, E Aguilera Xiol, A Meli, J Bobi, G Frigola and 16 more

Open access · greenAbstract readRandomized Controlled Trial, Veterinary
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.0field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 10 institutions in 3 countries.

D Battaglini *Division of Animal Experimentation, Department of Pulmonology, Hospital Clínic, Barcelona, Spain.
A Motos *Division of Animal Experimentation, Department of Pulmonology, Hospital Clínic, Barcelona, Spain.
G Li Bassi *Division of Animal Experimentation, Department of Pulmonology, Hospital Clínic, Barcelona, Spain.
H YangDivision of Animal Experimentation, Department of Pulmonology, Hospital Clínic, Barcelona, Spain.
F PagliaraDivision of Animal Experimentation, Department of Pulmonology, Hospital Clínic, Barcelona, Spain.
M YangDivision of Animal Experimentation, Department of Pulmonology, Hospital Clínic, Barcelona, Spain.
E Aguilera XiolDivision of Animal Experimentation, Department of Pulmonology, Hospital Clínic, Barcelona, Spain.
A MeliDivision of Animal Experimentation, Department of Pulmonology, Hospital Clínic, Barcelona, Spain.
J BobiDivision of Animal Experimentation, Department of Pulmonology, Hospital Clínic, Barcelona, Spain.
G FrigolaDepartamento de Anatomía Patológica, Hospital Clínic de Barcelona, Barcelona, Spain.
T SenussiDivision of Animal Experimentation, Department of Pulmonology, Hospital Clínic, Barcelona, Spain.
F IdoneDivision of Animal Experimentation, Department of Pulmonology, Hospital Clínic, Barcelona, Spain.
C TraviersoDivision of Animal Experimentation, Department of Pulmonology, Hospital Clínic, Barcelona, Spain.
C ChiurazziDivision of Animal Experimentation, Department of Pulmonology, Hospital Clínic, Barcelona, Spain.
L Fernandez-BaratDivision of Animal Experimentation, Department of Pulmonology, Hospital Clínic, Barcelona, Spain.
M RigolDivision of Animal Experimentation, Department of Pulmonology, Hospital Clínic, Barcelona, Spain.
J RamirezDepartamento de Anatomía Patológica, Hospital Clínic de Barcelona, Barcelona, Spain.
P PelosiDepartment of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genoa, Italy.
D ChiumelloUniversity of Milan, Milan, Italy.
M AntonelliDepartment of Anesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
D P NicolauCenter for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA.ORCID 0000-0002-4148-0165
J BringueDepartment of Intensive Care Medicine, CIBER Enfermedades Respiratorias, Corporacion Sanitaria Universitaria Parc Tauli, Autonomous University of Barcelona, Sabadell, Spain.
A ArtigasDepartment of Intensive Care Medicine, CIBER Enfermedades Respiratorias, Corporacion Sanitaria Universitaria Parc Tauli, Autonomous University of Barcelona, Sabadell, Spain.
L GuerreroDivision of Animal Experimentation, Department of Pulmonology, Hospital Clínic, Barcelona, Spain.
D SoyDivision of Medicines, Pharmacy Service, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
A TorresDivision of Animal Experimentation, Department of Pulmonology, Hospital Clínic, Barcelona, Spain atorres@clinic.cat.ORCID 0000-0002-8643-2167
Hospital Clínic de Barcelona · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESUniversity of Milan · ITUniversitat Autònoma de Barcelona · ESAgostino Gemelli University Polyclinic · ITHartford Hospital · USHumanitas University · ITOspedale Policlinico San Martino · ITUniversità Cattolica del Sacro Cuore · ITUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current guidelines recommend vancomycin and linezolid as first-line agents against methicillin-resistant

Indexed as

Methicillin-Resistant Staphylococcus aureusPneumonia, StaphylococcalAminoglycosidesAnimalsAnti-Bacterial AgentsLinezolidLipoglycopeptidesSwineAminoglycosidesAnti-Bacterial AgentsLinezolidLipoglycopeptidestelavancinanimal modelslinezolidmechanical ventilationMRSApigporcine modelsevere pneumoniatelavancin

Identifiers

PMID33046500
PMCPMC7927834
OpenAlexW3092355036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.